The Little Antibody That Could

A new, more targeted approach to treating autoimmune disorders may stop Type 1 diabetes

There are plenty of reasons not to tell you about an experimental new treatment for Type 1 diabetes, a particularly devastating form of diabetes in which the body's immune system attacks the insulin-producing cells of the pancreas. Experimental therapies often fail, and even when the treatments work, widespread availability is usually years away. But a study in last week's New England Journal of Medicine offers such intriguing insights into the future of treatment--not just for Type 1 diabetes but also for a number of autoimmune disorders--that it's hard to resist. Just keep in mind that these are preliminary results.

First a...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!